Deutsche Märkte öffnen in 5 Stunden 52 Minuten

Globus Medical, Inc. (GMED)

NYSE - Nasdaq Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
69,59+0,25 (+0,36%)
Börsenschluss: 04:00PM EDT
69,57 -0,02 (-0,03%)
Nachbörse: 06:51PM EDT

Globus Medical, Inc.

2560 General Armistead Avenue
Audubon, PA 19403
United States
610 930 1800
https://www.globusmedical.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter5.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. David C. PaulCo-Founder & Executive Chairman1,21MN/A1967
Mr. Daniel T. ScavillaPresident, CEO & Director1,67MN/A1965
Mr. Keith W. PfeilCFO & COO884,04k759,99k1979
Ms. Kelly G. Huller Esq.Senior VP, General Counsel & Secretary729,34kN/A1972
Mr. Brian J. KearnsSenior Vice President of Business Development & Investor RelationsN/AN/A1967
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Corporate Governance

Globus Medical, Inc.s ISS Governance QualityScore, Stand 18. September 2024, lautet 10. Die grundlegenden Scores sind Audit: 7, Vorstand: 10, Shareholderrechte: 10, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.